FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

Abstract Background Acne vulgaris has increased in women over the past 10 years; it currently affects 20–30% of women. The physiopathology of adult female acne is distinguished from that of teenagers essentially by two factors: hormonal and inflammatory. On a therapeutic plan, the four types of syst...

Full description

Bibliographic Details
Main Authors: Alexandra Poinas, Marie Lemoigne, Sarah Le Naour, Jean-Michel Nguyen, Solène Schirr-Bonnans, Valery-Pierre Riche, Florence Vrignaud, Laurent Machet, Jean-Paul Claudel, Marie-Thérèse Leccia, Ewa Hainaut, Nathalie Beneton, Cécile Dert, Aurélie Boisrobert, Laurent Flet, Anne Chiffoleau, Stéphane Corvec, Amir Khammari, Brigitte Dréno
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
Acne vulgaris
Spironolactone
Cycline
Online Access:http://link.springer.com/article/10.1186/s13063-020-04432-w

Internet

http://link.springer.com/article/10.1186/s13063-020-04432-w

Similar Items